Emergent BioSolutions Inc.·4

Mar 15, 5:16 PM ET

Glessner Coleen 4

4 · Emergent BioSolutions Inc. · Filed Mar 15, 2024

Insider Transaction Report

Form 4
Period: 2024-03-13
Glessner Coleen
EVP, Quality & Ethics, and CPL
Transactions
  • Award

    Employee Stock Options (Right to Buy)

    2024-03-13+125,000187,113 total
    Exercise: $2.33Exp: 2031-03-12Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

Documents

1 file
  • 4
    wk-form4_1710537364.xmlPrimary

    FORM 4